Skip to main content

Fiscal Wizard · Single-issue tearsheet

CPRX / Jun 20, 2026 Run #7230

CPRX

Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Composite verdict

A 93.0 / 100
Bullish setup · Directional State 7 drivers · 3 gates blocking
  • Accumulation/Distribution Line
  • 52-Week Proximity
  • Aroon Oscillator
Consider long call target Δ ~0.70 · ~35 DTE Bullish setup, Grade A → ITM call target

Industry rank 4th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 15 signals0% Bear
Momentum Bullish 99Mean-reversion Neutral 50

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -59%
Asset value $7.80Earnings power value $23.46Price $31.38

Priced above its no-growth earnings power value ($23.46/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Strong

86.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Asset Turnover 100
Cash Conversion Cycle 0
OCF to Net Income 95
Inventory Turnover 11

Technicals Bullish

99.9 / 100

Bullish setup leads (Accumulation/Distribution Line, 52-Week Proximity, Aroon Oscillator); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Accumulation/Distribution Line 88
52-Week Proximity 80
Aroon Oscillator 79

Risk Gates

3 blocking 6 caution

3 guards active, 25 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for CPRX.